Clinical Trial Update: How to Prevent Heart Failure Readmission by Using Lung Impedance Device (HOPE-HF Study) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update investigates preventing heart failure readmissions using a lung impedance device (HOPE-HF study).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: Heart Failure Acute | Phase 3 | Status: UNKNOWN